| 1 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 2 |
Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis, Management and Prevention of chronic Obstructive Pulmonary Disease[R]. 2019.
|
| 3 |
Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis[J]. J Glob Health, 2015, 5: 020415.
|
| 4 |
GBD 2013 Mortality and Causes of Death Collaborators. Global, regional，and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2015, 385(9963): 117-171.
|
| 5 |
Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections[J]. Eur Respir J, 2006, 27(2): 397-412.
|
| 6 |
World Health Organization. Projections of mortality and causes of death, 2015 and 2030. accessed 14 October 2018)．
URL
|
| 7 |
慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组．慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2017年更新版)[J]. 国际呼吸杂志，2017, 7(14): 041-1057.
|
| 8 |
Turak O, Özcan F, Işleyen A, et al. Usefulness of neutrophil-to-lymphocyte ratio to predict in-hospital outcomes in infective endocarditic[J]. Can J Cardiol, 2013, 29(12): 1672-1678.
|
| 9 |
Mcdonough JE, Yuan R, Suzuki M, et al. Small-Airway Obstruction and Emphysema in Chronic Obstructive Pulmonary Disease[J]. N Engl J Med, 2011, 365(17): 1567-1575.
|
| 10 |
Huang X, Zhu Z, Guo X, et al. The roles of microRNAs in the pathogenesis of chronic obstructive pulmonary disease[J]. Int Immunopharmacol, 2019, 67: 335-347.
|
| 11 |
Stockley RA. Progression of chronic obstructive pulmonary disease: impact of inflammation, comorbidities and therapeutic intervention[J]. Curr Med Res Opin, 2009, 25(5): 1235-1245.
|
| 12 |
Stockley RA. Neutrophils and the Pathogenesis of COPD[J]. Chest, 2002, 121(5): 151S-155S.
|
| 13 |
Butler A, Walton GM, Sapey E. Neutrophilic Inflammation in the Pathogenesis of Chronic Obstructive Pulmonary Disease[J]. COPD, 2018, 15(4): 392-404.
|
| 14 |
Wagner JG, Roth RA. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature[J]. Pharmacol Rev, 2000, 52(3): 349-374.
|
| 15 |
Macnee W. Pathogenesis of chronic obstructive pulmonary disease[J]．Clin Chest Med, 2007, 28(3): 479-513.
|
| 16 |
Stoller JK, Aboussouan LS. A review of α1-antitrypsin deficiency[J]. Am J Respir Crit Care Med, 2012, 185(3): 246-259.
|
| 17 |
Balbi B, Ferrarotti I, Miravitlles M. Efficacy of augmentation therapy for emphysema associated with alpha1-antitrypsin deficiency: enough is enough[J]. Eur Respir J, 2016, 47(1): 35-38.
|
| 18 |
Stockley RA, Miravitlles M, Vogelmeier C. Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach[J]. Orphanet J Rare Dis, 2013, 8: 149.
|
| 19 |
Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease[J]. Lancet, 2011, 378(9795): 1015-1026.
|
| 20 |
Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease[J]. Annu Rev Pathol, 2009, 4(1): 435-459.
|
| 21 |
Enelow RI, Mohammed AZ, Stoler MH, et al. Structural and functional consequences of alveolar cell recognition by CD8 (+) T lymphocytes in experimental lung disease[J]．J Clin Invest, 1998, 102(9): 1653-1661.
|
| 22 |
Finkelstein R, Fraser RS, Ghezzo H, et al. Alveolar inflammation and its relation to emphysema in smokers[J]. Am J Respir Crit Care Med, 1995, 152(5 Pt 1): 1666-1672.
|
| 23 |
Taylan M, Demir M, Kaya H, et al. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients[J]. Clin Respir J, 2017, 11(3): 311-317.
|
| 24 |
Bilir B, Altıntaş N, Aydın M. The predictive role of neutrophil to lymphocyte ratio in chronic obstructive pulmonary disease[J]. Eur J Gen Med, 2016, 13(2): 105-110.
|
| 25 |
Furutate R, Ishii T, Motegi T, et al. The Neutrophil to Lymphocyte Ratio Is Related to Disease Severity and Exacerbation in Patients with Chronic Obstructive Pulmonary Disease [J]. Intern Med, 2016, 55(3): 223-229.
|
| 26 |
Xiong W, Xu M, Zhao Y, et al. Can we predict the prognosis of COPD with a routine blood test？[J]. Int J Chron Obstruct Pulmon Dis, 2017, 12: 615-625.
|
| 27 |
Yasar Z, Buyuksirin M, Ucsular FD, et al. Is an elevated neutrophil-to-lymphocyte ratio a predictor of metabolic syndrome in patients with chronic obstructive pulmonary disease？[J]. Eur Rev Med Pharmacol Sci, 2015, 19(6): 956-962.
|
| 28 |
Aksoy E, Karakurt Z, Gungor S, et al. Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes[J]. Int J Chron Obstruct Pulmon Dis, 2018, 13: 2721-2730.
|
| 29 |
Günay E, Sarınç Ulaşlı S, Akar O, et al. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study[J]. Inflammation, 2014, 37(2): 374-380.
|
| 30 |
Duyar SS, Solak Y, Tekis D, et al. Platelet to lymphocyte ratio as a novel prognostic marker in male patients with chronic obstructive pulmonary disease[J]. Int J Respir Pulm Med, 2016, 3(1): 43.
|
| 31 |
Teng F, Ye H, Xue T. Predictive value of neutrophil to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. PLoS ONE, 2018, 13(9): e0204377.
|
| 32 |
Watz H, Waschki B, Kirsten A, et al. The Metabolic Syndrome in Patients With Chronic Bronchitis and COPD Frequency and Associated Consequences for Systemic Inflammation and Physical Inactivity[J]. Chest, 2009, 136(4): 1039-1046.
|
| 33 |
Yasar Z, Buyuksirin M, Ucsular FD, et al. Is an elevated neutrophil-to-lymphocyte ratio a predictor of metabolic syndrome in patients with chronic obstructive pulmonary disease？[J]. Eur Rev Med Pharmacol Sci, 2015, 19(6): 956-962.
|
| 34 |
叶 涛，杨 银，王 凯，等. 中性粒细胞/淋巴细胞比率预测慢性阻塞性肺疾病患者并发2型糖尿病的价值：前瞻性队列研究[J]. 南方医科大学学报，2017, 37(10): 1308-1314.
|